Stifel raised the firm’s price target on Trupanion (TRUP) to $44 from $42 and keeps a Hold rating on the shares. Risk-based capital requirements for the company increased modestly quarter-over-quarter following declines in Q1 and Q2 of 2024, the analyst tells investors.